Comparative Genomics of Two Sequential Candida glabrata Clinical Isolates
Open accessPublished version of a preprint
Abstract
Candida glabrata is an important fungal pathogen which develops rapid antifungal resistance in treated patients. It is known that azole treatments lead to antifungal resistance in this fungal species and that multidrug efflux transporters are involved in this process. Specific mutations in the transcriptional regulator PDR1 result in upregulation of the transporters. In addition, we showed that the PDR1 mutations can contribute to enhance virulence in animal models. In this study, we were interested to compare genomes of two specific C. glabrata-related isolates, one of which was azole susceptible (DSY562) while the other was azole resistant (DSY565). DSY565 contained a PDR1 mutation (L280F) and was isolated after a time-lapse of 50 d of azole therapy. We expected that genome comparisons between both isolates could reveal additional mutations reflecting host adaptation or even additional resistance mechanisms. The PacBio technology used here yielded 14 major contigs (sizes 0.18–1.6 Mb) and mitochondrial genomes from both DSY562 and DSY565 isolates that were highly similar to each other. Comparisons of the clinical genomes with the published CBS138 genome indicated important genome rearrangements, but not between the clinical strains. Among the unique features, several retrotransposons were identified in the genomes of the investigated clinical isolates. DSY562 and DSY565 each contained a large set of adhesin-like genes (101 and 107, respectively), which exceed by far the number of reported adhesins (63) in the CBS138 genome. Comparison between DSY562 and DSY565 yielded 17 nonsynonymous SNPs (among which the was the expected PDR1 mutation) as well as small size indels in coding regions (11) but mainly in adhesin-like genes. The genomes contained a DNA mismatch repair allele of MSH2 known to be involved in the so-called hyper-mutator phenotype of this yeast species and the number of accumulated mutations between both clinical isolates is consistent with the presence of a MSH2 defect. In conclusion, this study is the first to compare genomes of C. glabrata sequential clinical isolates using the PacBio technology as an approach. The genomes of these isolates taken in the same patient at two different time points exhibited limited variations, even if submitted to the host pressure.
AI snapshot
Written from the paper’s full text.
TL;DR
This study sequenced and compared two sequential *Candida glabrata* clinical isolates, azole-susceptible DSY562 and azole-resistant DSY565, using PacBio long-read assembly. The genomes were highly similar, with the expected PDR1 L280F resistance mutation, limited SNP/indel differences, extensive adhesin-like gene repertoires, and evidence consistent with an MSH2-associated hypermutator background.
Key findings
- PacBio assembly yielded 14 major contigs for DSY562 and 15 for DSY565, with N50s of 1,178,607 bp and 1,064,616 bp, respectively; total assembled bases were 12,729,188 bp for DSY562 and 12,728,164 bp for DSY565, a difference of 1,024 nucleotides.
- DSY562 and DSY565 differed by 17 nonsynonymous SNPs, including the expected PDR1 L280F substitution in DSY565, plus 11 indels in coding regions; most coding indels (7 of 11) were in adhesin-like genes.
- DSY562 contained 101 adhesin-like genes and DSY565 contained 107, with 95 shared; this exceeds the 63 adhesins reported for CBS138. The two clinical genomes also contained retrotransposon-like Tkp5 genes, and DSY565 lacked Tkp5-7 while retaining a single LTR at that locus.
- Compared with CBS138, the clinical isolates showed major chromosomal rearrangements, but DSY562 and DSY565 had highly similar chromosome arrangements; CHEF separations corresponded well to assembly predictions (R² = 0.981).
Methods
- Two sequential *C. glabrata* isolates from an HIV-positive patient with oropharyngeal candidiasis were studied: DSY562 was azole susceptible, and DSY565 was isolated after 50 d of fluconazole therapy and was azole resistant.
- Genomes were sequenced with PacBio RSII and assembled de novo using HGAP3; Illumina paired-end sequencing, RNAseq, Sanger sequencing, MLST, CHEF, and adhesin-prediction pipelines were also used.
- Genome comparisons used Geneious/Mauve and CLC Genomics Workbench to detect SNPs, indels, rearrangements, shared/unique CDS, introns, and adhesin-like genes.
Limitations
- The paper states that it cannot yet confirm whether the high adhesin repertoire (>100 genes) is unique to these isolates or shared across *C. glabrata* clades, and it attributes the 101 vs. 107 adhesin difference between DSY562 and DSY565 to technical assembly issues rather than true expansion.
- The paper states that PacBio misassemblies cannot be excluded for some larger deletions/insertions, especially near chromosome ends and repetitive sequences; homopolymer indels were systematically Sanger-verified, with only 8 of 108 confirmed.
- The paper notes that only successful clinical progenitors were sampled, which likely underestimates diversity, and that the functional consequences of most nonsynonymous changes remain unclear. Evident from the text: Chr J was incompletely assembled in DSY565, and small contigs enriched in adhesin genes could not be mapped to chromosomes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 42 cited sources checked · 0 supported · 0 flagged
- Findingown data
65 CDS from CBS138 were not detected in DSY562 and DSY565.
“65 CDS from CBS138 were not detected in DSY562 and DSY565 (Figure 3 and File S3).”
Quote in the paperSubstantial claim - Findingown data
The left arms of Chr L and C were inverted as compared to CBS138.
“The left arms of Chr L and C were inverted as compared to CBS138.”
Quote in the paperSubstantial claim - Findingown data
Nuclear and mitochondrial genomes diverged by 0.7% between DSY562 and CBS138.
“Nuclear and mitochondrial genomes diverged by 0.7% between the two strains.”
Quote in the paperSubstantial claim - Findingown data
The number of CDS in mitochondrial DNA and the numbers of tRNA were identical between DSY562, DSY565, and CBS138.
“Table 4 indicates that the number of CDS in mitochondrial DNA and numbers of tRNA were identical between strains.”
Quote in the paperNot a substantial claim - Findingown data
The CHEF analysis yielded an R2 value of 0.981 when plotting relative migration distance of known CBS138 chromosome sizes against obtained DSY562 and DSY565 chromosome sizes.
“Plotting the relative migration distance (Rf values) of known CBS138 chromosome sizes with the obtained sizes of DSY562 and DSY565 chromosomes yielded an R2 value of 0.981.”
Quote in the paperNot a substantial claim
- Findingown data
About 50% of the adhesin genes in DSY562 are located near telomeric ends, within 50 kb of chromosome ends.
“∼50% of the adhesin genes were located in DSY562, near to the telomeric ends (region of 50 kb down to chromosome ends) of the chromosomes.”
Quote in the paperNot a substantial claim - Findingown data
DSY562 contains 101 adhesin-like proteins, exceeding the 66 deduced in CBS138.
“According to our analysis, we proposed a list of 101 adhesin-like proteins in DSY562 (File S5 and File S6), which well exceeds the number of deduced adhesins in CBS138 (66) according to de Groot et al. (2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites de Groot et al. (2013) source
Not checked in the free run.
- Findingown data
The data highlight several chromosomal rearrangements between DSY562 and CBS138.
“The data highlight several chromosomal rearrangements between the two isolates.”
Quote in the paperSubstantial claim - Findingown data
A high number of SNPs occurred in genes encoding adhesins.
“A high number of SNPs occurred in genes encoding adhesins, and the following section will discuss the resolution of this important gene category.”
Quote in the paperNot a substantial claim - Findingown data
DSY565 contained a PDR1 mutation L280F.
“DSY565 contained a PDR1 mutation (L280F) and was isolated after a time-lapse of 50 d of azole therapy.”
Quote in the paperSubstantial claim - Findingown data
The repertoire of adhesins in DSY565 is very similar to that of DSY562.
“Notably, the repertoire of adhesins in DSY565 is very similar to DSY562 (Figure S1, see below).”
Quote in the paperNot a substantial claim - Findingown data
RNAseq data from DSY562 and DSY565 showed that 114 and 115 splice sites, respectively, coincided with the predicted splice sites.
“RNAseq data from DSY562 and DSY565 showed that 114 and 115 splice sites, respectively, coincided with the predicted splice sites (File S4).”
Quote in the paperNot a substantial claim - Findingown data
Other common genes between the DSY strains underwent duplication events, including B1J91/B1J92_D02794g, B1J91/B1J92_M05115g, B1J91/B1J92_H04257g, and B1J91/B1J92_H04279g.
“Other common genes between DSY strains underwent duplication events, including B1J91/B1J92_D02794g (endoplasmic reticulum membrane protein), B1J91/B1J92_M05115g (a putative retrotransposon protein), B1J91/B1J92_H04257g, and B1J91/B1J92_H04279g (encoding copper metallothionein MT-II and MT-IIB in DSY562 and DSY565 respectively).”
Quote in the paperNot a substantial claim - Findingown data
Nine genes from DSY562 and DSY565, named Tkp5-1 to Tkp5-9, were most similar to the Tkp5 protein from Vanderwaltozyma polyspora, a type of protein that encodes elements of Ty-like retrotransposons.
“Nine genes originating from DSY562 and DSY565 (named here Tkp5-1 to -9) were most similar to the Tkp5 protein from Vanderwaltozyma polyspora. This type of protein encodes elements of Ty-like retrotransposons (see Discussion).”
Quote in the paperNot a substantial claim - Findingown data
Several retrotransposons were identified in the genomes of the investigated clinical isolates.
“Among the unique features, several retrotransposons were identified in the genomes of the investigated clinical isolates.”
Quote in the paperNot a substantial claim - Findingown data
B1J91/B1J92_E01309g (EKI1) exhibited an N-terminal deletion due to the use of other intron splicing compared to the CBS138 homolog.
“B1J91/ B1J92_E01309g (EKI1: choline kinase activity, a role in the phosphatidylcholine biosynthetic process) exhibited an N-terminal deletion due to the use of other intron splicing as compared to the CBS138 homolog.”
Quote in the paperNot a substantial claim - Findingown data
Some previously annotated tandem CDS in CBS138 now form a single CDS in DSY562, for example B1J91/B1J92_I02816g and B1J91/B1J92_I02838g (AZF1) generate a single CDS B1J91/B1J92_I02838g.
“We also noticed that some previously annotated tandem CDS in CBS138 were now forming a single CDS in DSY562. For example, B1J91/B1J92_I02816g and B1J91/B1J92_I02838g (AZF1: asparagine-rich zinc finger protein) were now generating a single CDS (B1J91/B1J92_I02838g) in DSY562.”
Quote in the paperNot a substantial claim - Findingown data
Only 5225 CDS were shared between DSY562, DSY565, and CBS138.
“when comparing the CDS of each isolate, only a total of 5225 CDS were shared between them.”
Quote in the paperSubstantial claim - Findingown data
The number of deduced CDS in DSY562 was 5294, near the 5293 predicted CDS from CBS138.
“As observed from Table 4, the number of deduced CDS (locus tag prefix B1J91) in DSY562 was 5294, which was near to the 5293 predicted CDS from CBS138.”
Quote in the paperNot a substantial claim - Findingown data
MATα1 is still present in DSY562 and DSY565 but as another CDS, B1J91/B1J92_B00242g.
“Notably, MATα1 is still present in DSY562 and DSY565 but as another CDS (B1J91/B1J92_B00242g).”
Quote in the paperNot a substantial claim - Findingown data
Most of the genes gained in DSY562 and DSY565 as compared to CBS138 belonged to adhesin-like genes (34).
“When inspecting the identity of these 61 genes, we found that most of the genes gained in DSY562 and DSY565 as compared to CBS138 belonged to adhesin-like genes (34).”
Quote in the paperNot a substantial claim - Findingown data
Duplication of specific EPAs occurred in DSY562 for EPA2, EPA6, EPA8, EPA12, and EPA22.
“Duplication of specific EPAs occurred in DSY562 for EPA2, EPA6, EPA8, EPA12, and EPA22.”
Quote in the paperNot a substantial claim - Findingown data
The DSY565 genome yielded 5298 CDS.
“The DSY565 genome was next annotated on the basis of DSY562 annotations with the same Geneious tool and yielded 5298 CDS (locus tag prefix B1J92).”
Quote in the paperNot a substantial claim - Findingown data
B1J91/B1J92_D00154g (AQY1) was truncated in DSY562 and DSY565, with a CDS length of 459 bp compared to 873 bp in CBS138.
“For example, B1J91/B1J92_D00154g (AQY1, role in ion transport) was truncated in DSY562 and DSY565 (CDS length of 459 bp) as compared to CBS138 (CDS length of 873 bp).”
Quote in the paperNot a substantial claim - Findingcitation
Most of the remaining CBS138-specific genes were of unknown function (48).
“Most of the remaining CBS138-specific genes were of unknown function (48) (see details on File S3).”
Quote in the paperNot a substantial claim - Findingown data
Chr C, D, J, and M in DSY562 underwent exchanges from CBS138 chromosomes essentially at chromosomal extremities.
“Chr C, D, J, and M in DSY562 underwent exchanges from CBS138 chromosomes essentially at chromosomal extremities.”
Quote in the paperSubstantial claim - Findingown data
The genomes of DSY562 and DSY565, taken from the same patient at two different time points, exhibited limited variations even under host pressure.
“The genomes of these isolates taken in the same patient at two different time points exhibited limited variations, even if submitted to the host pressure.”
Quote in the paperSubstantial claim - Findingown data
The remaining 10 genes out of the 61 common to DSY562 and DSY565 were ranked as pseudogenes in the current CGD, explaining their absence from the CBS genome used in the analysis.
“The remaining 10 genes out of the 61 common to DSY562 and DSY565 were ranked as pseudogenes in the current CGD (some of which are also described as adhesin-like genes), thus explaining their absence from the CBS genome used in our analysis.”
Quote in the paperNot a substantial claim - Findingown data
The high number of nonsynonymous SNPs (11,014) underscores a large number of amino acid substitutions.
“The high number of nonsynonymous SNPs (11,014) underscores a large number of amino acid substitutions.”
Quote in the paperNot a substantial claim - Findingown data
Assembled contigs almost reconstituted the entire set of chromosomes known from the CBS138 genome.
“Assembled contigs almost reconstituted the entire set of chromosomes that is known from the CBS138 genome.”
Quote in the paperSubstantial claim - Findingown data
Chr D and L were joined to the shortened Chr I, renamed Chr I-L-D.
“Chr D and L were joined to the shortened Chr I (which was renamed as Chr I-L-D).”
Quote in the paperSubstantial claim - Findingcitation
The genomes contained a DNA mismatch repair allele of MSH2 known to be involved in the hyper-mutator phenotype of this yeast species.
“The genomes contained a DNA mismatch repair allele of MSH2 known to be involved in the so-called hyper-mutator phenotype of this yeast species and the number of accumulated mutations between both clinical isolates is consistent with the presence of a MSH2 defect.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Healey et al. 2016b
Not checked in the free run.
- Findingown data
The close relationship between DSY562 and DSY565 reported earlier is confirmed by the high level of similarity between the sequenced genomes.
“The close relationship between these two isolates reported earlier (Sanglard et al. 1999) is confirmed here by the high level of similarity between the sequenced genomes.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sanglard et al. 1999 source
Not checked in the free run.
- Findingown data
This retrotransposon was not identified in another location in DSY565.
“This retrotransposon was not identified in another location in DSY565.”
Quote in the paperNot a substantial claim - Findingown data
A size difference of ∼29 kb exists at the left arm of Chr C between DSY562 and DSY565.
“A size difference of ∼29 kb exists at the left arm of Chr C between DSY562 and DSY565 (Figure S1).”
Quote in the paperNot a substantial claim - Findingown data
Most indels in the DSY562 vs DSY565 comparison were in homopolymeric sequences, which are long stretches of 10-30 identical nucleotides, 108 in total.
“First we noticed that most of the indels in these comparisons were in homopolymeric sequences, which are long stretches (10–30) of identical nucleotides (108 in total).”
Quote in the paperNot a substantial claim - Findingown data
Another well-distinguished cluster lacked both VSHITT and PA14 motifs and contained CBS138 AWP homologs AWP6 and -7.
“Another well-distinguished cluster lacked both VSHITT and PA14 motifs and contained CBS138 AWP homologs (AWP6 and -7).”
Quote in the paperNot a substantial claim - Findingown data
95 adhesins were shared between DSY562 and DSY565.
“95 adhesins were shared between both isolates (Figure 6)”
Quote in the paperNot a substantial claim - Findingown data
DSY565 has retained a single long terminal repeat (LTR) at the Tkp5-7 locus as a trace of the retrotransposon.
“Interestingly, DSY565 has retained a single long terminal repeat (LTR) at this locus as a trace of the presence of the retrotransposon.”
Quote in the paperNot a substantial claim - Findingown data
The largest cluster of DSY562 adhesin-like proteins contained VSHITT-motif repeats and PA14 motifs but lacked EPA signatures.
“The largest cluster of proteins contained VSHITT-motif repeats and PA14 motifs, however, they lacked EPA signatures (green color of Figure 5).”
Quote in the paperNot a substantial claim - Findingcitation
DSY562 and DSY565 carry a V239L nonsynonymous mutation in MSH2.
“Interestingly, DSY562 and DSY565 carry a V239L nonsynonymous mutation in MSH2, which is known to favor this hyper-mutator phenotype (Healey et al. 2016b).”
Quote in the paperSubstantial claim - Findingown data
The majority of the novel adhesin-like proteins in DSY562 exhibited VSHITT domains.
“The majority of the novel proteins exhibited VSHITT domains.”
Quote in the paperNot a substantial claim - Findingown data
VSHITT-motif repeats were also found in another cluster that essentially lacked PA14 motifs.
“VSHITT-motif repeats were also found in another cluster (red color of Figure 5) that essentially lacked PA14 motifs.”
Quote in the paperNot a substantial claim - Findingown data
Larger deletions and insertions were identified in coding sequences between DSY562 and DSY565.
“Besides these nonsynonymous SNPs, larger deletions an insertions were identified in coding sequences (Table 8).”
Quote in the paperNot a substantial claim - Findingown data
The largest extension occurred for adhesin-like proteins with VSHITT repeats that include members of the PWP and AWP family.
“The largest extension occurred for adhesin-like proteins with VSHITT repeats that include members of the PWP and AWP family (Figure 5).”
Quote in the paperNot a substantial claim - Findingown data
The transcription factor CgPDR1 harbored the L280F substitution in DSY565.
“As expected, the transcription factor CgPDR1 harbored the L280F substitution in DSY565.”
Quote in the paperSubstantial claim - Findingown data
The other nonsynonymous SNPs were located in genes not known to be associated with drug resistance.
“The other nonsynonymous SNPs were located in genes not known to be associated with drug resistance.”
Quote in the paperNot a substantial claim - Findingown data
The discrepancies between the DSY562 and DSY565 genomes were principally due to the presence of adhesin-like genes in small contigs that could not be mapped to the chromosomes.
“the discrepancies between the two genomes were principally due to the presence of adhesin-like genes in small contigs, which could not be mapped to the chromosomes (Figure S1).”
Quote in the paperNot a substantial claim - Findingown data
DSY562 possesses one gene (B1J91_E00110g1) located at the extremity of Chr J that is not present in DSY565 (Chr J1).
“In addition, DSY562 possesses one gene (B1J91_E00110g1) located at the extremity of Chr J that is not present in DSY565 (Chr J1).”
Quote in the paperNot a substantial claim - Findingown data
DSY565 lacks the retrotransposon Tkp5-7 that is situated at the right arm of Chr M in DSY562.
“Another major difference between DSY562 and DSY565 is that DSY565 lacks the retrotransposon Tkp5-7 that is situated at the right arm of Chr M in DSY562.”
- Also stated in: § Discussion · plain
“Notably, DSY565 did not retain Tkp5-7, which is otherwise situated at the right arm of Chr M in DSY562.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingcitation
This grouping is less complex than proposed earlier using CBS138 data (seven clusters).
“This grouping is less complex than proposed earlier using CBS138 data (seven clusters) (de Groot et al. 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites de Groot et al. 2008 source
Not checked in the free run.
- Findingcitation
These Ty-like retrotransposon genes (Tkp5-1 to -9) were most similar to the Tkp5 protein from V. polyspora.
“These Ty-like retrotransposons genes (named here Tkp5-1 to -9) were most similar to the Tkp5 protein from V. polyspora, a yeast representing the postwhole-genome duplication lineage most divergent from S. cerevisiae (Scannell et al. 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Scannell et al. 2007 source
Not checked in the free run.
- Findingnone given
At the genomic level, DSY562 and DSY565 underwent several major chromosomal rearrangements.
“At the genomic level, DSY562 and DSY565 underwent several major chromosomal rearrangements.”
Quote in the paperSubstantial claim - Findingnone given
Tpk5-1 shared the C-terminal ends of Tpk5-3 and -4.
“Tpk5-1 shared the C-terminal ends of Tpk5-3 and -4.”
Quote in the paperNot a substantial claim - Findingown data
DSY562 and DSY565 genomes harbored transposon-like genes not reported previously in C. glabrata.
“Besides the above-mentioned SNPs, the DSY562 and DSY565 genomes harbored transposon-like genes not reported previously in C. glabrata.”
Quote in the paperSubstantial claim - Findingreasoning
Six nonhomopolymeric indels were identified by genome comparisons between DSY562 and DSY565.
“Other indels in nonhomopolymeric sequences (14 indels − 8 indels in homopolymeric sequences = 6) were identified by genome comparisons between DSY562 and DSY565.”
Quote in the paperNot a substantial claim - Findingown data
12 and three adhesin-like and unique genes were identified in the small contigs of DSY565 and DSY562, respectively.
“12 and three adhesin-like and unique genes were identified in the small contigs of DSY565 and DSY562, respectively.”
Quote in the paperNot a substantial claim - Findingown data
A total of 17 nonsynonymous SNPs were identified between DSY562 and DSY565.
“A total of 17 nonsynonymous SNPs were identified between both genomes (Table 7).”
- Also stated in: § Discussion · plain
“We noticed only 17 nonsynonymous changes between these isolates (Table 7).”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
The majority of these deletions/insertions (7 out of 11) were observed in adhesin-like genes.
“The majority of these deletions/insertions (7 out of 11) were observed in adhesin-like genes.”
- Also stated in: § Discussion · plain
“Other larger changes were detected between both strains (Table 8) and they occurred mainly in adhesin-like genes.”
Quote in the paperNot a substantial claim - Also stated in: § Discussion · plain
- Findingown data
With hierarchical clustering and mapping of PFAM and functional domains, we could distinguish four major groups including EPA-like genes, two VSHIT-containing groups, and another group with genes lacking EPA and VSHIT signatures.
“With this approach, we could distinguish four major groups including the EPA-like genes, two VSHIT-containing groups, and another group with genes lacking EPA and VSHIT signatures.”
Quote in the paperSubstantial claim - Findingown data
Comparison between the DSY genomes and the three published pairs using the same chromosomal fragments highlighted divergences as high as those between DSY isolates and CBS138.
“Comparison between the DSY genomes and the three published pairs using the same chromosomal fragments highlighted divergences as high as those between DSY isolates and CBS138.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Håvelsrud and Gaustad 2017
Not checked in the free run.
- Interpretationown data
The size difference between Chr C of DSY562 and CBS138 may be explained by the tandem arrangement of a group of four adhesins.
“The size difference between Chr C between DSY562 and CBS138 may be explained by the tandem arrangement of a group of four adhesins.”
Quote in the paperNot a substantial claim - Interpretationnone given
This study is the first to compare genomes of Candida glabrata sequential clinical isolates using PacBio technology.
“In conclusion, this study is the first to compare genomes of C. glabrata sequential clinical isolates using the PacBio technology as an approach.”
Quote in the paperSubstantial claim - Study design and conductcitation
The high relationship between DSY562 and DSY565 was confirmed by MLST typing.
“Before undertaking genome sequencing, both isolates were subjected to MLST typing according to Dodgson et al. (2005) (Table 1), and thus the high relationship between both isolates was confirmed.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dodgson et al. (2005) source
Not checked in the free run.
- Study design and conductown data
Size predictions from the assemblies corresponded well to physical chromosome separations by CHEF.
“Remarkably, size predictions from the assemblies corresponded well to physical separations (see Figure 2).”
Quote in the paperSubstantial claim - Study design and conductown data
The PacBio assemblies for DSY562 and DSY565 were of high quality.
“N50s were 1.06 and 1.17 Mb for both isolates, thus highlighting the high quality of the assemblies.”
Quote in the paperSubstantial claim - Premisecitation
DSY565 acquired azole resistance within a time-lapse of 50 days from DSY562 in a patient with oropharyngeal candidiasis.
“At the same time, it became also pertinent to compare the genome of this isolate with one (DSY565) that acquired azole resistance within a time-lapse of 50 d from DSY562 in a patient with oropharyngeal candidiasis (Sanglard et al. 1999).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sanglard et al. 1999 source
Not checked in the free run.
- Premisecitation
Specific Candida glabrata isolates exhibit upregulation of the adhesin EPA1 when the transcriptional activator responsible for azole resistance CgPDR1 is mutated.
“Specific isolates exhibit upregulation of the adhesin EPA1 when the transcriptional activator responsible for azole resistance CgPDR1 is mutated.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vale-Silva et al. 2016
Not checked in the free run.
- Premisecitation
The only available Candida glabrata genome up to now is from the isolate CBS138.
“however the only available C. glabrata genome is up to now from the isolate CBS138 (Dujon et al. 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dujon et al. 2004 source
Not checked in the free run.
- Interpretationreasoning
The number of accumulated mutations between DSY562 and DSY565 is consistent with the presence of a MSH2 defect.
“The genomes contained a DNA mismatch repair allele of MSH2 known to be involved in the so-called hyper-mutator phenotype of this yeast species and the number of accumulated mutations between both clinical isolates is consistent with the presence of a MSH2 defect.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Healey et al. 2016b
Not checked in the free run.
- Interpretationown data
Several selection events resulted in the loss and gain of several genes between DSY562, DSY565, and CBS138.
“These above-mentioned results suggest that several selection events resulted in the loss and gain of several genes between these strains.”
Quote in the paperSubstantial claim - Premisecitation
A genome report on a separate C. glabrata isolate closely related to CBS138 identified 49 adhesin-like genes.
“A genome report on a separate C. glabrata isolate closely related to CBS138 identified 49 adhesin-like genes (Xu et al. 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xu et al. 2016
Not checked in the free run.
- Interpretationcitation
High genetic diversity exists between C. glabrata isolates of different origins.
“This underlines the high genetic diversity existing between C. glabrata isolates of different origins which has been observed by others using different approaches.”
- Also stated in: § Discussion · plain
“Taken together, these studies underline the high genetic diversity existing between C. glabrata isolates of different origins.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Interpretationreasoning
Taking into account the data of Table 7 and Table 8, the number of SNPs and indels between DSY562 and DSY565 are in agreement with numbers reported in S. cerevisiae.
“Taking into account the data of Table 7 and Table 8, the number of SNPs and indels between DSY562 and DSY565 are in agreement with numbers reported in S. cerevisiae.”
Quote in the paperSubstantial claim - Interpretationreasoning
All these data suggested the potential presence of other adhesins in the genetic background of DSY562 and its related strain DSY565.
“All these data suggested the potential presence of other adhesins in the genetic background of DSY562 and its related strain DSY565.”
Quote in the paperSubstantial claim- Rests on an assumption: Virulence traits may be multifactorial.
- Premisecitation
The L280F mutation is known to be sufficient to mediate azole resistance in C. glabrata.
“This mutation is known to be sufficient to mediate azole resistance in C. glabrata (Ferrari et al. 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ferrari et al. 2009
Not checked in the free run.
- Premisecitation
Azole resistance in DSY565 was due to a mutation in the transcription factor CgPDR1.
“We reported that azole resistance was due to a mutation in the transcription factor CgPDR1.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Ferrari et al. 2009
Not checked in the free run.
- cites Vale-Silva et al. 2016
Not checked in the free run.
- Premisecitation
The V239L mutation in MSH2 is known to favor the hyper-mutator phenotype.
“Interestingly, DSY562 and DSY565 carry a V239L nonsynonymous mutation in MSH2, which is known to favor this hyper-mutator phenotype (Healey et al. 2016b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Healey et al. 2016b
Not checked in the free run.
- Premisecitation
A separate study demonstrated that DSY562 was the C. glabrata isolate with the highest capacity among those tested to bind C. albicans hyphae.
“Interestingly, a separate study demonstrated that DSY562 was a C. glabrata isolate with the highest capacity among those tested to bind C. albicans hyphae (Tati et al. 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tati et al. 2016
Not checked in the free run.
- Premisecitation
The C. glabrata isolate CCTCC M202019 was remarkably closely related to CBS138, with 205 SNP differences.
“Interestingly, this C. glabrata isolate was remarkably closely related to CBS138 (205 SNP differences) (Xu et al. 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xu et al. 2016
Not checked in the free run.
- Study design and conductreasoning
We only sampled successful progenitors from the clinic, which strongly reduces the diversity of isolates for further analysis.
“We only sampled successful progenitors from the clinic, which of course strongly reduces the diversity of isolates for further analysis.”
Quote in the paperSubstantial claim - Interpretationown data
In proportion to the size of their genomes, the number of changes between the DSY strains is rather small.
“In proportion to the size of their genomes, the number of changes between the DSY strains is rather small.”
Quote in the paperNot a substantial claim - Study design and conductown data
The presence of the six nonhomopolymeric indels was confirmed by separate genome alignment with Illumina reads.
“Their presence was confirmed by separate genome alignment with Illumina reads obtained in the early stage of the project (data not shown).”
Quote in the paperNot a substantial claim - Interpretationreasoning
We attribute the difference in adhesin counts to technical issues during the assembly of PacBio reads.
“We rather attribute this difference to technical issues during the assembly of PacBio reads.”
Quote in the paperSubstantial claim- Rests on an assumption: PacBio sequencing can yield indel differences in homopolymeric sequences.
- Interpretationreasoning
Genetic diversity by the MSH2 defect may be much higher than observed from the collected clinical strains.
“This underpins that genetic diversity by the MSH2 defect may be much higher than observed from the collected clinical strains.”
Quote in the paperSubstantial claim - Interpretationreasoning
It is unlikely that the discrepancy between 101 and 107 adhesins could reflect an expansion of adhesins in DSY565 as compared to DSY562 in such a short time-lapse between sampling of isolates.
“It is unlikely that this discrepancy could reflect an expansion of adhesins in DSY565 as compared to DSY562 in such a short time-lapse between sampling of isolates.”
Quote in the paperSubstantial claim - Premisecitation
The CgPDR1 mutation in DSY565 contributed to increased virulence compared to a parental strain, as measured in different animal models.
“This mutation was contributing to an increase of virulence as compared to a parental strain and was measured in different animal models (Ferrari et al. 2009; Vale-Silva et al. 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ferrari et al. 2009
Not checked in the free run.
- cites Vale-Silva et al. 2016
Not checked in the free run.
- Interpretationcitation
The number of generations that occurred within the time-lapse of DSY562 and DSY565 isolation may correspond to at least 250-500 generations, taking into account 5-10 generations/d according to published data.
“The number of generations that occurred within the time-lapse of DSY562 and DSY565 isolation may correspond to at least 250–500 generations, when taking into account 5–10 generations/d according to published data (Forche et al. 2009; Roetzer et al. 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationown data
Given that a single LTR remained at the Tkp5-7 location in DSY565, this suggests an active transposition system.
“Given that a single LTR remained at this location in DSY565, this suggests an active transposition system.”
Quote in the paperSubstantial claim
- May combine two claims. 48
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 12
May combine two claims.
Findingown dataDSY562 and DSY565 genomes possessed at least 144 intron-containing genes, close to the 150 identified in CBS130.
“Table 5 shows that DSY562 and DSY565 genomes possessed at least 144 intron-containing genes, which is close to the number identified in CBS130 (150).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataChr A, B, E, G, H, and K kept similar structures between DSY562 and CBS138, while other chromosomes underwent several modifications.
“While Chr A, B, E, G, H, and K kept similar structures between both strains, other chromosomes underwent several modifications.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataB1J91/B1J92_C02343g (ARB1) contains an intron in CBS138 but lacks a reading frame in DSY562 and DSY565; removal of the intron restores a truncated CDS compared to CBS138.
“B1J91/B1J92_C02343g (ARB1: a protein with ATPase activity and a role in cellular response to drugs, a ribosomal small subunit exported from the nucleus and cytosol), which contains an intron in CBS138, lacks a reading frame in DSY562 and DSY565. Removal of the intron in this gene restores a truncated CDS as compared to CBS138.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenCandida glabrata DSY562 and DSY565 are paired clinical isolates that were isolated from an HIV-positive patient presenting oropharyngeal candidiasis.
“C. glabrata DSY562 and DSY565 are paired clinical isolates that were isolated from an HIV-positive patient presenting oropharyngeal candidiasis.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataB1J91/B1J92_H04257g and B1J91/B1J92_H04279g were found in four tandem repeats on Chr H in DSY562 and DSY565, whereas CBS138 has only one repeat.
“Interestingly, B1J91/B1J92_H04257g and B1J91/B1J92_H04279g were found in four tandem repeats on Chr H as opposed to CBS138, in which only one repeat is found.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataComparison between DSY562 and DSY565 yielded 17 nonsynonymous SNPs, including the expected PDR1 mutation, and 11 small size indels in coding regions, mainly in adhesin-like genes.
“Comparison between DSY562 and DSY565 yielded 17 nonsynonymous SNPs (among which the was the expected PDR1 mutation) as well as small size indels in coding regions (11) but mainly in adhesin-like genes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDSY562 and DSY565 each contained a large set of adhesin-like genes (101 and 107, respectively), exceeding the 63 reported adhesins in the CBS138 genome.
“DSY562 and DSY565 each contained a large set of adhesin-like genes (101 and 107, respectively), which exceed by far the number of reported adhesins (63) in the CBS138 genome.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites de Groot et al. 2013 source
Not checked in the free run.
May combine two claims.
Findingown dataIllumina reads of DSY562 and DSY565 aligned to the CBS138 genome at approximately 95%, with coverage of 72-fold and 64-fold, respectively.
“In both cases, ∼95% of reads aligned to the CBS genomes and coverage was 72- to 64-fold for DSY562 and DSY565 data, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataB1J91/B1J92_M05687g (NPY1), B1J91/B1J92_G03487g (TMN3), B1J91/B1J92_I10725g (YGR122W), B1J91/B1J92_E01155g (RPA14), and B1J91/B1J92_H06017g (FLR1) exhibit N-terminal truncated proteins as compared to CBS138.
“B1J91/B1J92_M05687g (NPY1: has NAD+ diphosphatase activity and a role in the NADH metabolic process), B1J91/B1J92_G03487g (TMN3: has a role in cellular copper ion homeostasis), B1J91/B1J92_I10725g (YGR122W: has a role in negative regulation of transcription from the RNA polymerase II promoter), B1J91/B1J92_E01155g (RPA14: RNA polymerase I activity), and B1J91/B1J92_H06017g (FLR1: a multidrug tran”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataParts of Chr L and I were added to Chr F, renamed Chr F-L-I, in DSY562, yielding the largest chromosome in this species at 1.59 Mb.
“Parts of Chr L and I were added to Chr F (which was renamed as Chr F-L-I) in DSY562, thus yielding the largest chromosome in this species (1.59 Mb).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe 65 CBS138-specific genes included, among others, 6 adhesin-like genes, CAGL0B01243g (MATα1), and CAGL0G07175g, an RNA binding protein with RNA-directed DNA polymerase activity.
“Genes that were CBS138 specific (65) included, among others, adhesin-like genes (6), CAGL0B01243g (MATα1), and CAGL0G07175g (RNA binding protein with RNA-directed DNA polymerase activity).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMembers of the EPA family (19) in DSY562 were well discerned in the phylogenetic tree and harbor typical EPA adhesin signatures, including a PA14 domain and EPA-specific domains, except B1J91_K00170g4.
“Members of the EPA family (19) were well discerned in this tree (blue color of Figure 5) and harbor typical signatures of EPA adhesins, including a PA14 domain as well as EPA-specific domains (see details in Material and Methods), with the exception of B1J91_K00170g4.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe separate DSY565 assembly yielded the same chromosome arrangement as DSY562, except that Chr J was not completely assembled and was split into Chr J1 and J2.
“Remarkably, the separate DSY565 assembly yielded the same chromosome arrangement as DSY562, with the exception that Chr J was not completely assembled in DSY565. This chromosome was still split in two parts (Chr J1 and J2; see Table 4 and Figure S1) in DSY565.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPacBio sequencing yielded 14 major contigs and mitochondrial genomes from both DSY562 and DSY565 that were highly similar to each other.
“The PacBio technology used here yielded 14 major contigs (sizes 0.18–1.6 Mb) and mitochondrial genomes from both DSY562 and DSY565 isolates that were highly similar to each other.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data78 CDS from DSY562 and DSY565 were not found in CBS138, and 61 of these were common to DSY562 and DSY565.
“78 CDS from DSY562 and DSY565 were not found in CBS138. From these 78 CDS, 61 were common to DSY562 and DSY565; thus highlighting unique CDS for each of the strains.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
Findingown dataDSY562 and DSY565 both belong to sequence type ST8.
“DSY562 | ST8 | 4 | 0.25 | 0.5 | — | —”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datarDNAs were identified in DSY562 and DSY565 and were located at the telomeric ends of Chr L and M-J as in CBS138.
“rDNAs were identified in DSY562 and DSY565, and were located at the telomeric ends of Chr L and M-J as in CBS138.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThere are approximately 370,000 nucleotide differences between the CBS138 and DSY562 genomes, with DSY562 having the largest genome.
“It is interesting to observe that there are ∼370000 nt differences between the CBS138 and DSY562 genomes (the latter having the largest genome), thus highlighting that additional/novel genes may be present in the DSY strains (see below).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe difference in nucleotide counts for major contigs including mitochondrial DNA is larger (58,400 nucleotides), compensated by nucleotide counts of small contigs that could not be consistently assembled to larger contigs.
“The difference in nucleotide counts for major contigs (including mitochondrial DNA) is larger (58,400 nucleotides), however this is compensated for by nucleotide counts of the small contigs which could not be consistently assembled to larger contigs.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataComparisons of the clinical genomes with the published CBS138 genome indicated important genome rearrangements, but not between the clinical strains.
“Comparisons of the clinical genomes with the published CBS138 genome indicated important genome rearrangements, but not between the clinical strains.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIllumina comparisons of DSY562 and DSY565 with CBS138 yielded 85,711-85,986 changes including SNPs and indels and approximately 10,390 nonsynonymous changes.
“Both comparisons yielded a high number of changes (85,711–85,986 including SNPs and indels) and resulted in ∼10,390 nonsynonymous changes as compared to CBS138.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPacBio major assembled contigs larger than 20 kb numbered 14 for DSY562 and 15 for DSY565, with N50s of 1.06 and 1.17 Mb.
“As summarized in this table, the number of major assembled contigs (size >20 kb) were 14 and 15 for DSY562 and DSY565, respectively. N50s were 1.06 and 1.17 Mb for both isolates, thus highlighting the high quality of the assemblies.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationDSY565 was isolated after 50 days of fluconazole therapy and exhibited azole resistance.
“DSY565 was isolated after 50 d of fluconazole therapy and exhibited azole resistance (Sanglard et al. 1999) (Table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Sanglard et al. 1999 source
Not checked in the free run.
May combine two claims.
Findingown dataDSY562 and DSY565 accounted for totals of 12,729,188 and 12,728,164 nucleotides, a difference of 1024 nucleotides between the two genomes.
“DSY562 and DSY565 accounted for totals of 12,729,188 and 12,728,164 nucleotides. This represents a difference of 1024 nucleotides between the two genomes.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTpk5-2 and Tpk5-5 to -9 encoded the same proteins, while Tpk5-3 and -4 were different (66% identity) but still similar to the Tkp5 protein from V. polyspora.
“We observed that, while Tpk5-2 and Tpk5-5 to -9 encoded the same proteins, Tpk5-3 and -4 were different (66% identity) but still similar to the Tkp5 protein from V. polyspora.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataA tandem repeat of B1J91_C01067g is present in DSY562 at the Chr C extremity, while only one copy remained in DSY565.
“While a tandem repeat of B1J91_C01067g is present in DSY562 at the Chr C extremity, only one copy remained in DSY565.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationChr D-L and Chr L inversions, as well as Chr I-L-D, are among common chromosome patterns, while Chr F-L-I and Chr C inversions seem unique to DSY562 and DSY565.
“While Chr D-L and Chr L inversions, as well as Chr I-L-D are among the common patterns, Chr F-L-I and Chr C inversions seem unique to DSY562 and DSY565.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Carreté et al. 2017
Not checked in the free run.
May combine two claims.
Findingown dataWe determined the presence of >100 adhesin-like genes in both DSY strains, which was not yet anticipated from other genome-wide studies.
“We determined the presence of >100 adhesin-like genes in both DSY strains, which was not yet anticipated from other genome-wide studies.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningCBS138 and CCTCC M202019 do not exhibit MSH2 defects and they contain a limited repertoire of adhesins as compared to DSY562/DSY565.
“In agreement with our hypothesis, it is interesting to mention that CBS138 and CCTCC M202019 do not exhibit MSH2 defects and they contain a limited repertoire of adhesins as compared to DSY562/DSY565.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xu et al. 2016
Not checked in the free run.
May combine two claims.
Findingown dataOnly eight of the 108 putative homopolymeric indels were confirmed by Sanger sequencing; 95 out of 108 were corrected.
“Only eight of these indels were confirmed by this approach (95 out of 108 were corrected; see Table 6 and File S7).”
Quote in the paperSubstantial claim- Rests on an assumption: PacBio sequencing can yield indel differences in homopolymeric sequences.
May combine two claims.
Findingown dataTpk5-1 was located next to B1J91/B1J92_M05115g on Chr G, which is described as similar to Ty5-6, a S. paradoxus retrotransposon; both genes are flanked by the same LTR.
“Curiously, Tpk5-1 was located next to B1J91/B1J92_M05115g on Chr G, which is described as similar to Ty5-6, a S. paradoxus retrotransposon. Both genes are flanked by the same LTR.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe data suggest that 61 novel adhesin-like proteins were assigned to DSY562, while 40 remained in common with CBS138, considering only 50 adhesin-like proteins without frameshifts.
“Taken together, the data suggest that 61 novel adhesin-like proteins were assigned to DSY562, while 40 remained in common with CBS138 (Figure 5, only 50 adhesin-like proteins without frameshifts were taken into account in these calculations).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThese reads produced small contigs, as illustrated in Figure S1, which are enriched in adhesin genes.
“These reads produced small contigs, as illustrated in Figure S1, which are enriched in adhesin genes.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningTpk5-2 and Tpk5-5 to -9 were flanked by the same LTRs, while Tpk5-3 and -4 were flanked by other distinct LTRs.
“As expected from retrotransposons, Tpk5-2 and Tpk5-5 to -9 were flanked by the same LTRs, while Tpk5-3 and -4 were flanked by other distinct LTRs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data101 adhesin-like genes were identified in DSY562 and 107 in DSY565.
“While 101 adhesin-like genes were identified in DSY562, 107 adhesin-like genes were found in DSY565 (Figure S1).”
- Also stated in: § Discussion · plain
“The number of identified adhesins between both isolates differs substantially (101 in DSY562 vs. 107 in DSY565).”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
May combine two claims.
Findingown dataThe overlay between both groupings showed consistently that cluster I contained the EPA-like genes and that clusters V and VII and clusters II and III were grouped in two categories that include VSHIT-containing adhesins.
“The overlay between both grouping showed consistently that cluster I contained the EPA-like genes and that clusters V and VII and clusters II and III were grouped in two categories that include VSHIT-containing adhesins.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe other clusters (IV and VI) are located in distinct branches, the latter being grouped in genes lacking EPA and VSHIT signatures.
“The other clusters (IV and VI) are located in distinct branches, the latter being grouped in genes lacking EPA and VSHIT signatures.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Premisenone givenSpecific mutations in the transcriptional regulator PDR1 result in upregulation of multidrug efflux transporters in Candida glabrata.
“Specific mutations in the transcriptional regulator PDR1 result in upregulation of the transporters.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCandida glabrata azole resistance is coupled with selective fitness advantages in animal models of infection.
“We have shown in the past years that C. glabrata azole resistance is coupled with selective fitness advantages in animal models of infection (Ferrari et al. 2009; Vale-Silva et al. 2013).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Ferrari et al. 2009
Not checked in the free run.
- cites Vale-Silva et al. 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationWhen EPA1 is upregulated, Candida glabrata exhibits increased adherence to host cells, which contributes to enhanced virulence of this yeast species.
“When EPA1 is upregulated, the consequence is that C. glabrata exhibits increased adherence to host cells, which is one of the factors that contributes to enhance virulence of this yeast species which develops azole resistance (Vale-Silva et al. 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vale-Silva et al. 2016
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCandida glabrata can exhibit high mutation rates in the presence of antifungal agents, based on decreased activity of the DNA repair machinery in specific clinical isolates.
“It has been shown recently that C. glabrata can exhibit high mutation rates in the presence of antifungal agents. This property is based on the decreased activity of the DNA repair machinery that exists in specific clinical isolates (Healey et al. 2016b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Healey et al. 2016b
Not checked in the free run.
May combine two claims.
Study design and conductown dataThe identified changes do not reflect PacBio errors because the DSY562 and DSY565 assemblies were produced independently and produced the same changes compared to CBS138, and Sanger sequencing confirmed the absence of PacBio errors.
“We believe that these changes do not reflect PacBio errors since (i) the DSY562 and DSY565 assemblies were produced independently to produce the same changes as compared to CBS138, and (ii) Sanger sequencing verifications confirmed the absence of PacBio errors [see example of B1J91/B1J92_H06017g (FLR1) sequencing in Figure S2].”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataAdditional or novel genes may be present in the DSY strains.
“It is interesting to observe that there are ∼370000 nt differences between the CBS138 and DSY562 genomes (the latter having the largest genome), thus highlighting that additional/novel genes may be present in the DSY strains (see below).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe discrepancy of Chr K from DSY562 from expected CBS138 patterns may be due to intrinsic chromosome size variations observed by others for this type of strain.
“Chr K from DSY562 showed a discrepancy from the expected patterns from CBS138, however this result may be due to intrinsic chromosome size variations observed by others for this type of strain (Bader et al. 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bader et al. 2012
Not checked in the free run.
May combine two claims.
InterpretationreasoningAnother homolog, B1J91/B1J92_A01221g, is present in DSY562 and DSY565 and likely compensates for the probable loss of function of B1J91/B1J92_D00154g.
“Interestingly, another homolog is present in DSY562 and DSY565 (B1J91/B1J92_A01221g), thus likely compensating for the probable loss of function of B1J91/B1J92_D00154g.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCandida glabrata azole resistance is mediated principally by efflux-dependent mechanisms, while candin resistance is the consequence of mutations in FKS1 and FKS2 encoding the candin target enzyme beta-glucan synthase.
“While C. glabrata azole resistance is mediated principally by efflux-dependent mechanisms, candin resistance is the consequence of mutations in the genes (FKS1 and FKS2) encoding the candin target enzyme (β-glucan synthase) (Perlin 2015; Vale-Silva and Sanglard 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Perlin 2015
Not checked in the free run.
- cites Vale-Silva and Sanglard 2015
Not checked in the free run.
May combine two claims.
Interpretationown dataThe data indicate extensive divergence between the DSY562 and CBS138 genomes, in general agreement with analyses from other Candida glabrata genomes.
“These data indicate extensive divergence between the two genomes, however they are in general agreement with the analysis deduced from other C. glabrata genomes (Singh-Babak et al. 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Singh-Babak et al. 2012 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCandida glabrata contains 63 ORFs with adhesin properties.
“It is estimated that C. glabrata contains 63 ORFs with adhesin properties (de Groot et al. 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites de Groot et al. 2013 source
Not checked in the free run.
May combine two claims.
Study design and conductown dataA PCR-based approach confirmed the absence of Tkp5-7 in DSY565 while leaving the LTR signature.
“A PCR-based approach confirmed the absence of Tkp5-7 in DSY565 while leaving the LTR signature (see Figure S3).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationThe mismatch-repair gene MSH2 can modulate drug resistance when its activity is compromised by specific SNPs, giving rise to a hyper-mutator phenotype.
“It has been reported earlier that the mismatch-repair gene MSH2 can modulate drug resistance when its activity is compromised by specific SNPs, giving rise to a hyper-mutator phenotype (Healey et al. 2016b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Healey et al. 2016b
Not checked in the free run.
May combine two claims.
Interpretationown dataThese features suggest that DSY562 and DSY565 have acquired retrotransposons from different sources and that these strains have undergone several transposition events.
“Taken together, these features suggest that DSY562 and DSY565 have acquired retrotransposons from different sources and that these strains have undergone several transposition events.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe current literature on DNA mismatch-repair defects highlighted that the occurrence of mutations is not random: DNA regions with a greater density of repeats are more mutable in mismatch-repair defective cells.
“The current literature on the effect of DNA mismatch-repair defects also highlighted that the occurrence of mutations is not random: DNA regions with a greater density of repeats are more mutable in mismatch-repair defective cells (Ma et al. 2012; Lang et al. 2013).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Ma et al. 2012
Not checked in the free run.
- cites Lang et al. 2013 source
Not checked in the free run.
May combine two claims.
Interpretationown dataThis number exceeds by far the numbers published for CBS138 (50-66, depending on criteria) and therefore suggests that an expansion of this gene family occurred in our isolates.
“This number exceeds by far the numbers published for CBS138 (50–66, depending on the criteria used for selection) and therefore suggests that an expansion of this gene family occurred in our isolates.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationBinding of C. glabrata to C. albicans hyphae involved the C. albicans Als3 adhesin.
“Binding of C. glabrata involved the C. albicans Als3 adhesin.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tati et al. 2016
Not checked in the free run.
May combine two claims.
Premisecitation44-50% of investigated isolates (n = 625) were carrying MSH2 defects, which indicates that the MSH2 defect may confer some selective advantage in C. glabrata.
“It has been observed that 44–50% of investigated isolates (n = 625) were carrying MSH2 defects which thus indicates that the MSH2 defect may confer some selective advantage in C. glabrata (Dellière et al. 2016; Healey et al. 2016a,b).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Dellière et al. 2016 source
Not checked in the free run.
- cites Healey et al. 2016a,b
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe absence of B1J91_E00110g1 in DSY565 may be due to incomplete assembly of Chr J1 in this isolate.
“This may be due to incomplete assembly of Chr J1 in this isolate.”
Quote in the paperNot a substantial claim- Rests on an assumption: Chromosome ends are recalcitrant to correct assembly and include repetitive sequences.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningIt is likely that recombination events in chromosome-end regions may generate variations that could result in a beneficial phenotype for the fungus.
“It is likely that recombination events in these regions may generate variations which could result in a beneficial phenotype for the fungus.”
Quote in the paperNot a substantial claim- Rests on an assumption: Chromosome ends are recalcitrant to correct assembly and include repetitive sequences.
May combine two claims.
PremisecitationDSY562, the parent of DSY565, was intrinsically highly adherent to host cells even with the lowest EPA1 expression levels compared to other tested strains, with a PDR1 wild-type allele.
“On the other hand, we observed that DSY562, the parent of DSY565, was intrinsically highly adherent to host cells, even with the lowest EPA1 expression levels as compared to other tested strains. This intrinsically high adherence capacity was observed with a PDR1 wild-type allele (Vale-Silva et al. 2016).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vale-Silva et al. 2016
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese genes probably form part of chromosomal ends, but remain presently unassembled to major contigs.
“These genes probably form part of chromosomal ends, but remain presently unassembled to major contigs.”
Quote in the paperSubstantial claim- Rests on an assumption: Chromosome ends are recalcitrant to correct assembly and include repetitive sequences.
The paper relies on this without support.
Virulence traits may be multifactorial.
“Given that virulence traits may be multifactorial, we reasoned that other mutations may contribute to this phenotype.”
The paper relies on this without support.
PacBio sequencing can yield indel differences in homopolymeric sequences.
“Since it is known that PacBio can yield these differences, we undertook systematic verifications of these sequences by separate Sanger sequencing of small PCR fragments comprising these putative indels.”
The paper relies on this without support.
Chromosome ends are recalcitrant to correct assembly and include repetitive sequences.
“Some of the affected CDS are located near to chromosome ends, which are known to be recalcitrant to correct assembly and include repetitive sequences.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
DSY565, CMRL6, NRZ-2016-057, and NRZ-2016-058 were shown to be azole resistant.
“DSY565, CMRL6, NRZ-2016-057, and NRZ-2016-058 were shown to be azole resistant; and CMRL2, CMRL4, and NRZ-2016-058 were shown to be echinocandin resistant (Biswas et al., 2017; Vale-Silva et al., 2017; Barber et al., 2018).”
From Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations (2019) · cites this paper as Vale-Silva et al., 2017
The azole-resistant strain DSY565 presents a private non-synonymous mutation L280F in PDR1.
“As shown in another study (Vale-Silva et al., 2017), the azole-resistant DSY565 presents a private non-synonymous mutation (L280F) in PDR1”
From Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations (2019) · cites this paper as Vale-Silva et al., 2017
CMRL2, CMRL4, and NRZ-2016-058 were shown to be echinocandin resistant.
“DSY565, CMRL6, NRZ-2016-057, and NRZ-2016-058 were shown to be azole resistant; and CMRL2, CMRL4, and NRZ-2016-058 were shown to be echinocandin resistant (Biswas et al., 2017; Vale-Silva et al., 2017; Barber et al., 2018).”
From Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations (2019) · cites this paper as Vale-Silva et al., 2017
DSY562 and DSY565 both carry a V239L mutation in MSH2 and may display a faster evolutionary rate.
“In a previous analysis it was reported that DSY562 and DSY565 both carry a V239L mutation in MSH2 and that these strains may display a faster evolutionary rate (Vale-Silva et al., 2017).”
From Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations (2019) · cites this paper as Vale-Silva et al., 2017
Most strains within a pair showed a very low density of SNPs (0.037-0.047 SNPs/Kb), confirming their clonal nature.
“Similarly, most strains within a pair showed a very low density of SNPs (0.037–0.047 SNPs/Kb), confirming their clonal nature (Biswas et al., 2017; Vale-Silva et al., 2017; Carreté et al., 2018).”
From Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations (2019) · cites this paper as Vale-Silva et al., 2017
C. glabrata clinical isolates have varied numbers of adhesin-encoding genes and a distinct profile of cell wall proteins expressed at the cell surface.
“Moreover, C. glabrata clinical isolates are known to have varied number of adhesin-encoding genes, and a distinct profile of cell wall proteins expressed at the cell surface [41,48,49].”
From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [48]
The presence of a large number of adhesin genes and their complex environment-dependent differential regulation are likely to help C. glabrata colonize different host niches as well as form biofilms on a wide range of surfaces.
“Therefore, the presence of such a large number of adhesin genes and their complex environment-dependent differential regulation are likely to help C. glabrata colonize different host niches as well as to form biofilms on a wide range of surfaces [27,47,48].”
From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [48]
Two C. glabrata clinical isolates obtained from the same patient separated by 50 days of azole treatment had 17 non-synonymous SNPs, including one gain of function substitution in the PDR1 gene (L280F) and small-sized indels mainly affecting adhesin-like genes.
“The identified genetic differences comprised 17 non-synonymous SNPs, including one gain of function substitution in the PDR1 gene (L280F) and small-sized indels mainly affecting adhesin-like genes.”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
DNA dilution concentration is inconsistent with mass and volume
MinorDiluting 5 μg of DNA to 150 μl gives about 0.0333 μg/μl, not 30 μg/μl.
Reported 30 · recomputed 0.033333
“Aliquots of 5 μg of extracted, high-quality genomic DNA was diluted to 150 μl using elution buffer at 30 μg/μl.”
Uncorrected homopolymer indel count does not match
MinorIf 95 of 108 putative indels were corrected, 13 remained, rather than the stated eight confirmed indels.
Reported 8 · recomputed 13
“Only eight of these indels were confirmed by this approach (95 out of 108 were corrected; see Table 6 and File S7).”
Abstract understates DSY565 major-contig count
MinorThe abstract says both isolates yielded 14 major contigs, whereas Table 2 lists 15 for DSY565.
“The PacBio technology used here yielded 14 major contigs (sizes 0.18–1.6 Mb) and mitochondrial genomes from both DSY562 and DSY565 isolates”
“| Major contigs (including mitochondrial DNA) | 14 | 15 | 14 |”
Cites
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L. S., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,477 · see citing works
Mauve: Multiple alignment of conserved genomic sequence with rearrangements
Darling, A. C. E., Mau, B., Blattner, F. R., & Perna, N. T. (2004) · Genome Research · doi:10.1101/gr.2289704 · Cited by 4,949 · see citing works
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284 · see citing works
Dujon, B., Sherman, D., Fischer, G., Durrens, P., Casaregola, S., Lafontaine, I., de Montigny, J., Marck, C., Neuvéglise, C., Talla, E., et al. (2004) · Nature · doi:10.1038/nature02579 · Cited by 1,623 · see citing works
Yang, B.-J., Han, X., Yin, L.-L., Xing, M., Xu, Z. H., & Xue, H. (2016) · Nature Communications · doi:10.1038/ncomms11388 · Cited by 1,203 · see citing works
The complex transcriptional landscape of the anucleate human platelet
Bray, P. F., McKenzie, S. E., Edelstein, L. C., Nagalla, S., Delgrosso, K., Ertel, A., Kupper, J., Jing, Y., Londin, E., Loher, P., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-1 · Cited by 802 · see citing works
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · see citing works
Bain, C. C., Hawley, C. A., Garner, H., Scott, C. L., Schridde, A., Steers, N. J., Mack, M., Joshi, A., Guilliams, M., Mowat, A. M. I., et al. (2016) · Nature Communications · doi:10.1038/ncomms11852 · Cited by 527 · see citing works
Changing epidemiology of systemic fungal infections
Richardson, M., & Lass-Flörl, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01978.x · Cited by 524 · see citing works
Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000
Marchetti, O., Bille, J., Fluckiger, U., Eggimann, P., Ruef, C., Garbino, J., Calandra, T., Glauser, M., Tauber, M. G., Pittet, D., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380637 · Cited by 478 · see citing works
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 420 · see citing works
Self-citationEchinocandin resistance in Candida.
Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374 · see citing works
Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366 · see citing works
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337 · see citing works
Self-citationAdhesins in human fungal pathogens: glue with plenty of stick.
de Groot, P. W. J., Bader, O., de Boer, A. D., Weig, M., & Chauhan, N. (2013) · Eukaryotic Cell · doi:10.1128/ec.00364-12 · Cited by 319 · see citing works
Echinocandin resistance: an emerging clinical problem?
Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299 · see citing works
Ferrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · see citing works
Self-citationHealey, K. R., Zhao, Y., Perez, W. B., Lockhart, S. R., Sobel, J. D., Farmakiotis, D., Kontoyiannis, D. P., Sanglard, D., Taj-Aldeen, S. J., Alexander, B. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms11128 · Cited by 276 · see citing works
Self-citationScannell, D. R., Frank, A. C., Conant, G. C., Byrne, K. P., Woolfit, M., & Wolfe, K. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608218104 · Cited by 235 · cited 1× · see citing works
“These Ty-like retrotransposons genes (named here Tkp5-1 to -9) were most similar to the Tkp5 protein from Vanderwaltozyma polyspora, a yeast representing the post-whole genome duplication (WGD) lineage most divergent from Saccharomyces cerevisiae (Scannell et al. 2007).”
Methodde Groot, P. W. J., Kraneveld, E. A., Yin, Q. Y., Dekker, H. L., Groß, U., Crielaard, W., de Koster, C. G., Bader, O., Klis, F. M., & Weig, M. (2008) · Eukaryotic Cell · doi:10.1128/ec.00284-08 · Cited by 232 · see citing works
Pham, C. D., Iqbal, N., Bolden, C. B., Kuykendall, R. J., Harrison, L. H., Farley, M. M., Schaffner, W., Beldavs, Z. G., Chiller, T. M., Park, B. J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03255-14 · Cited by 231 · see citing works
He, D., Zhang, L., He, D., Zhou, G., Lin, Y., Deng, Z., Hong, X., Wu, Y. S., Chen, C., & Li, Y. (2016) · Nature Communications · doi:10.1038/ncomms12362 · Cited by 229 · see citing works
Calabrese, D. R., Billé, J., & Sanglard, D. (2000) · Microbiology · doi:10.1099/00221287-146-11-2743 · Cited by 210 · see citing works
Self-citationGlobal Analysis of the Evolution and Mechanism of Echinocandin Resistance in Candida glabrata
Singh-Babak, S. D., Babak, T., Diezmann, S., Hill, J. A., Xie, J. L., Chen, Y.-L., Poutanen, S. M., Rennie, R. P., Heitman, J., & Cowen, L. E. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002718 · Cited by 204 · cited 1× · see citing works
“These data indicate extensive divergence between the two genomes, however they are in general agreement with the analysis deduced from other C. glabrata genomes (Singh-Babak et al. 2012).”
ResultComparative genomics of emerging pathogens in the Candida glabrata clade.
Gabaldón, T., Martin, T., Marcet-Houben, M., Durrens, P., Bolotin-Fukuhara, M., Lespinet, O., Arnaise, S., Boisnard, S., Aguileta, G., Atanasova, R., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-623 · Cited by 198 · see citing works
Multilocus Sequence Typing of Candidaglabrata Reveals Geographically EnrichedClades
Dodgson, A. R., Pujol, C., Denning, D. W., Soll, D. R., & Fox, A. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5709-5717.2003 · Cited by 191 · see citing works
Update on Antifungal Drug Resistance
Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 174 · see citing works
Roetzer, A., Gabaldón, T., & Schüller, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02102.x · Cited by 154 · see citing works
Drug-Resistant<i>Candida glabrata</i>Infection in Cancer Patients
Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.140685 · Cited by 152 · see citing works
Evolution in<i>Candida albicans</i>Populations During a Single Passage Through a Mouse Host
Forche, A., Magee, P. T., Selmecki, A., Berman, J., & May, G. (2009) · Genetics · doi:10.1534/genetics.109.103325 · Cited by 147 · see citing works
Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144 · see citing works
Self-citationGlycan microarray analysis of <i>Candida glabrata</i> adhesin ligand specificity
Zupancic, M. L., Frieman, M., Smith, D., Alvarez, R. A., Cummings, R. D., & Cormack, B. P. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06184.x · Cited by 143 · see citing works
Tati, S., Davidow, P., McCall, A. D., Hwang-Wong, E., Rojas, I. G., Cormack, B. P., & Edgerton, M. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005522 · Cited by 142 · see citing works
Pfaller, M. A., Messer, S. A., Hollis, R. J., Boyken, L. B., Tendolkar, S., Kroeger, J. S., & Diekema, D. J. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00946-09 · Cited by 128 · see citing works
Blot, S. I. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01835.x · Cited by 124 · see citing works
Lang, G. I., Parsons, L., & Gammie, A. E. (2013) · G3 Genes Genomes Genetics · doi:10.1534/g3.113.006429 · Cited by 107 · see citing works
Weig, M. (2004) · Microbiology · doi:10.1099/mic.0.27256-0 · Cited by 104 · see citing works
Genetic Drivers of Multidrug Resistance in Candida glabrata
Healey, K. R., Jimenez Ortigosa, C., Shor, E., & Perlin, D. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01995 · Cited by 93 · see citing works
Pfaller, M. A., Messer, S. A., Boyken, L. B., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.5.2176-2179.2003 · Cited by 86 · see citing works
Barreto, T. A., de Andrade, S. C. A., Maciel, J. F., Arcanjo, N. M. O., Madruga, M. S., Meireles, B. R. L. D. A., Cordeiro, Â. M. T. D. M., de Souza, E. L., & Magnani, M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01724 · Cited by 86 · see citing works
Antifungal stewardship in invasive Candida infections
Ruhnke, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12622 · Cited by 85 · see citing works
FungalRV: adhesin prediction and immunoinformatics portal for human fungal pathogens
Chaudhuri, R., Ansari, F. A., Raghunandanan, M. V., & Ramachandran, S. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-192 · Cited by 79 · see citing works
J-Circos: an interactive Circos plotter
An, J., Lai, J., Sajjanhar, A., Batra, J., Wang, C., & Nelson, C. C. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu842 · Cited by 78 · see citing works
Defining the transcriptomic landscape of Candida glabrata by RNA-Seq
Linde, J., Duggan, S., Weber, M., Horn, F., Sieber, P. A., Hellwig, D., Riege, K., Marz, M., Martin, R., Guthke, R., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1357 · Cited by 75 · see citing works
Dellière, S., Healey, K., Gits-Muselli, M., Carrara, B., Barbaro, A., Guigue, N., Lecefel, C., Touratier, S., Desnos-Ollivier, M., Perlin, D. S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02038 · Cited by 75 · see citing works
Evidence for recombination in Candida glabrata.
Dodgson, A. R., Pujol, C., Pfaller, M. A., Denning, D. W., & Soll, D. R. (2005) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2004.11.010 · Cited by 69 · see citing works
Tipping the balance both ways: drug resistance and virulence in Candida glabrata
Vale-Silva, L. A., & Sanglard, D. (2015) · FEMS Yeast Research · doi:10.1093/femsyr/fov025 · Cited by 68 · see citing works
Self-citationVale-Silva, L., Ischer, F., Leibundgut-Landmann, S., & Sanglard, D. (2013) · Infection and Immunity · doi:10.1128/iai.00074-13 · Cited by 65 · see citing works
Self-citationVale-Silva, L. A., Moeckli, B., Torelli, R., Posteraro, B., Sanguinetti, M., & Sanglard, D. (2016) · mSphere · doi:10.1128/msphere.00065-15 · Cited by 51 · see citing works
Self-citationDiderrich, R., Kock, M., Maestre-Reyna, M., Keller, P., Steuber, H., Rupp, S., Essen, L.-O., & Mösch, H.-U. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655654 · Cited by 40 · see citing works
Bader, O., Schwarz, A., Kraneveld, E. A., Tangwattanchuleeporn, M., Schmidt, P., Jacobsen, M. D., Gross, U., De Groot, P. W. J., & Weig, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052218 · Cited by 39 · see citing works
Mutation Hot Spots in Yeast Caused by Long-Range Clustering of Homopolymeric Sequences
Ma, X., Rogacheva, M. V., Nishant, K. T., Zanders, S. E., Bustamante, C. D., & Alani, E. (2012) · Cell Reports · doi:10.1016/j.celrep.2011.10.003 · Cited by 34 · see citing works
Xu, N., Ye, C., Chen, X., Liu, J., Liu, L., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep34893 · Cited by 15 · see citing works
Draft Genome Sequences of Candida glabrata Isolates 1A, 1B, 2A, 2B, 3A, and 3B
Håvelsrud, O. E., & Gaustad, P. (2017) · Genome Announcements · doi:10.1128/genomea.00328-16 · Cited by 9 · see citing works
Carreté, L., Księżopolska, E., Pegueroles, C., Gómez-Molero, E., Saus, E., Iraola‐Guzmán, S., Loska, D., Bader, O., Fairhead, C., & Gabaldón, T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/105791 · Cited by 2 · see citing works
Flagged first, then by citations
3 of the 58 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230 · see citing works
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194 · see citing works
Candida glabrata: A Lot More Than Meets the Eye
Kumar, K., Askari, F., Sahu, M. S., & Kaur, R. (2019) · Microorganisms · doi:10.3390/microorganisms7020039 · Cited by 128 · see citing works
Timmermans, B., De Las Peñas, A., Castaño, I., & Van Dijck, P. (2018) · Journal of Fungi · doi:10.3390/jof4020060 · Cited by 109 · see citing works
Ksiezopolska, E., Schikora-Tamarit, M. À., Beyer, R., Nunez-Rodriguez, J. C., Schüller, C., & Gabaldón, T. (2021) · Current Biology · doi:10.1016/j.cub.2021.09.084 · Cited by 107 · see citing works
Divergent Approaches to Virulence in C. albicans and C. glabrata: Two Sides of the Same Coin
Galocha, M., Pais, P., Cavalheiro, M., Pereira, D., Viana, R., & Teixeira, M. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092345 · Cited by 105 · see citing works
Sugar Sensing and Signaling in Candida albicans and Candida glabrata
Ende, M. V., Wijnants, S., & Dijck, P. V. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00099 · Cited by 103 · see citing works
Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination
León, M. G. F.-D., Hernández‐Castro, R., Conde-Cuevas, E., García-Coronel, I. H., Vázquez-Aceituno, V. A., Soriano-Ursua, M. A., Farfán‐García, E. D., Ocharan-Hernández, M. E., Rodríguez‐Cerdeira, C., Arenas, R., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101529 · Cited by 78 · see citing works
Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae
Kannan, A., Asner, S. A., Trachsel, E., Kelly, S., Parker, J., & Sanglard, D. (2019) · mBio · doi:10.1128/mbio.02512-19 · Cited by 63 · see citing works
Self-citationEmergence and evolution of virulence in human pathogenic fungi
Siscar-Lewin, S., Hube, B., & Brunke, S. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.12.013 · Cited by 63 · see citing works
Carreté, L., Ksiezopolska, E., Gómez-Molero, E., Angoulvant, A., Bader, O., Fairhead, C., & Gabaldón, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00112 · Cited by 58 · see citing works
Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata
Healey, K., & Perlin, D. S. (2018) · doi:10.20944/preprints201808.0306.v1 · Cited by 194 · see citing works
Pais, P., Galocha, M., Viana, R., Cavalheiro, M., Pereira, D., & Teixeira, M. C. (2019) · Microbial Cell · doi:10.15698/mic2019.03.670 · Cited by 52 · see citing works
Xu, Z., Green, B., Benoit, N. E., Schatz, M. C., Wheelan, S. J., & Cormack, B. P. (2020) · Molecular Microbiology · doi:10.1111/mmi.14488 · Cited by 45 · see citing works
Cavalheiro, M., Costa, C., Silva-Dias, A., Miranda, I. M., Wang, C., Pais, P., Pinto, S. N., Mil-Homens, D., Sato-Okamoto, M., Takahashi-Nakaguchi, A., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00995-18 · Cited by 42 · see citing works
Single yeast cell nanomotions correlate with cellular activity
Willaert, R., Boer, P. V., Malovichko, A., Alioscha‐Perez, M., Radotić, K., Bartolić, D., Kalauzi, A. J., Villalba, M. I., Sanglard, D., Dietler, G., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba3139 · Cited by 43 · see citing works
Self-citationSanglard, D. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007478 · Cited by 39 · see citing works
Self-citationCandida glabrata: A powerhouse of resistance
Duggan, S., & Usher, J. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011651 · Cited by 37 · see citing works
Ni, Q., Wang, C., Tian, Y., Dong, D., Jiang, C., Mao, E., & Peng, Y. (2018) · Mycoses · doi:10.1111/myc.12756 · Cited by 38 · see citing works
Candida glabrata’s Genome Plasticity Confers a Unique Pattern of Expressed Cell Wall Proteins
López-Fuentes, E., Gutiérrez-Escobedo, G., Timmermans, B., Van Dijck, P., De Las Peñas, A., & Castaño, I. (2018) · Journal of Fungi · doi:10.3390/jof4020067 · Cited by 35 · see citing works
Long-Reads-Based Metagenomics in Clinical Diagnosis With a Special Focus on Fungal Infections
Hoang, M. T. V., Irinyi, L., Hu, Y., Schwessinger, B., & Meyer, W. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.708550 · Cited by 35 · see citing works
Evolutionary and genomic comparisons of hybrid uninucleate and nonhybrid Rhizoctonia fungi
Li, C., Guo, Z., Zhou, S., Han, Q., Zhang, M., Peng, Y., Hsiang, T., & Chen, X. (2021) · Communications Biology · doi:10.1038/s42003-021-01724-y · Cited by 33 · see citing works
Barber, A. E., Weber, M., Kaerger, K., Linde, J., Gölz, H., Duerschmied, D., Markert, A., Guthke, R., Walther, G., & Kurzai, O. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01628-18 · Cited by 32 · see citing works
Salazar, S. B., Wang, C., Münsterkötter, M., Okamoto, M., Takahashi-Nakaguchi, A., Chibana, H., Lopes, M. M., Güldener, U., Butler, G., & Mira, N. P. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/fox079 · Cited by 31 · see citing works
Valotteau, C., Prystopiuk, V., Cormack, B. P., & Dufrêne, Y. F. (2019) · mSphere · doi:10.1128/msphere.00277-19 · Cited by 29 · see citing works
Cell wall protein variation, break‐induced replication, and subtelomere dynamics in Candida glabrata
Xu, Z., Green, B., Benoit, N. E., Sobel, J. D., Schatz, M. C., Wheelan, S. J., & Cormack, B. P. (2021) · Molecular Microbiology · doi:10.1111/mmi.14707 · Cited by 27 · see citing works
Marcet‐Houben, M., Alvarado, M. I., Księżopolska, E., Saus, E., de Groot, P. W. J., & Gabaldón, T. (2022) · BMC Biology · doi:10.1186/s12915-022-01412-1 · Cited by 29 · see citing works
Gale, A. N., Pavesic, M. W., Nickels, T. J., Xu, Z., Cormack, B. P., & Cunningham, K. W. (2023) · mSphere · doi:10.1128/msphere.00254-23 · Cited by 27 · see citing works
A Noncanonical DNA Damage Checkpoint Response in a Major Fungal Pathogen
Shor, E., Garcia‐Rubio, R., DeGregorio, L., & Perlin, D. S. (2020) · mBio · doi:10.1128/mbio.03044-20 · Cited by 23 · see citing works
Antifungal resistance: Emerging mechanisms and implications (Review)
Kadariswantiningsih, I. N., Empitu, M. A., Santosa, T., & Alimu, Y. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13612 · Cited by 24 · see citing works
Gambhir, N., Harris, S. D., & Everhart, S. E. (2022) · mSphere · doi:10.1128/msphere.00087-22 · Cited by 18 · see citing works
Yeast metagenomics: analytical challenges in the analysis of the eukaryotic microbiome
Renzi, S., Nenciarini, S., Bacci, G., & Cavalieri, D. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2023.27 · Cited by 19 · see citing works
Maroc, L., Shaker, H., & Shapiro, R. S. (2024) · mSphere · doi:10.1128/msphere.00761-23 · Cited by 19 · see citing works
Misas, E., Seagle, E. E., Jenkins, E. N., Rajeev, M., Hurst, S. F., Nunnally, N. S., Bentz, M. L., Lyman, M., Berkow, E. L., Harrison, L. H., et al. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-23 · Cited by 18 · see citing works
Pais, P., Galocha, M., Takahashi‐Nakaguchi, A., Chibana, H., & Teixeira, M. C. (2022) · Microbial Cell · doi:10.15698/mic2022.11.786 · Cited by 15 · see citing works
Schrevens, S., Durandau, E., Tran, V. D. T., & Sanglard, D. (2022) · Virulence · doi:10.1080/21505594.2022.2095716 · Cited by 16 · see citing works
Self-citationArastehfar, A. A., Marcet‐Houben, M., Daneshnia, F., Taj‐Aldeen, S. J., Batra, D. G., Lockhart, S. R., Shor, E., Gabaldón, T., & Perlin, D. S. (2021) · Studies in Mycology · doi:10.1016/j.simyco.2021.100133 · Cited by 15 · see citing works
Salazar, S. B., Pinheiro, M. J. F., Sotti-Novais, D., Soares, A. R., Lopes, M. M., Ferreira, T., Rodrigues, V., Fernandes, F., & Mira, N. P. (2022) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkac110 · Cited by 15 · see citing works
Experimental and in-host evolution of triazole resistance in human pathogenic fungi
Handelman, M., & Osherov, N. (2022) · Frontiers in Fungal Biology · doi:10.3389/ffunb.2022.957577 · Cited by 14 · see citing works
Fernández-Pereira, J., Alvarado, M. I., Gómez-Molero, E., Dekker, H. L., Muñoz, M. T. B., Eraso, E., Bader, O., & de Groot, P. W. J. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.790465 · Cited by 13 · see citing works
RNAi as a Tool to Study Virulence in the Pathogenic Yeast Candida glabrata
Ishchuk, O. P., Ahmad, K. M., Koruza, K., Bojanovič, K., Sprenger, M., Kasper, L., Brunke, S., Hube, B., Säll, T., Hellmark, T., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01679 · Cited by 12 · see citing works
Hassoun, Y., Aptekmann, A. A., Keniya, M. V., Gomez, R. Y., Alayo, N., Novi, G., Quinteros, C., Kaya, F., Zimmerman, M. D., Caceres, D. H., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012521 · Cited by 11 · see citing works
Leiva-Peláez, O., Gutiérrez-Escobedo, G., López-Fuentes, E., Cruz-Mora, J., De Las Peñas, A., & Castaño, I. (2018) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2018.05.005 · Cited by 10 · see citing works
Molecular investigations on Candida glabrata clinical isolates for pharmacological targeting
Gupta, H., Gupta, P., Kairamkonda, M., & Poluri, K. M. (2022) · RSC Advances · doi:10.1039/d2ra02092k · Cited by 9 · see citing works
Chromatin architecture and virulence-related gene expression in eukaryotic microbial pathogens
Juárez‐Reyes, A., & Castaño, I. (2018) · Current Genetics · doi:10.1007/s00294-018-0903-z · Cited by 8 · see citing works
Investigating Candida glabrata Urinary Tract Infections (UTIs) in Mice Using Bioluminescence Imaging
Schrevens, S., & Sanglard, D. (2021) · Journal of Fungi · doi:10.3390/jof7100844 · Cited by 8 · see citing works
Self-citationMicroevolution of Candida glabrata (Nakaseomyces glabrata) during an infection
López-Marmolejo, A. L., Hernández-Chávez, M. J., Gutiérrez‐Escobedo, G., Herrera-Basurto, M. S., Mora-Montes, H. M., Peñas, A. D. L., & Castaño, I. (2024) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2024.103891 · Cited by 6 · see citing works
The Epithelial adhesin 1 tandem repeat region mediates protein display through multiple mechanisms
Raposo, C. J., McElroy, K. A., & Fuchs, S. M. (2020) · FEMS Yeast Research · doi:10.1093/femsyr/foaa018 · Cited by 4 · see citing works
Luca, D. G. D., Alexander, D. C., Dingle, T. C., Dufresne, P. J., Fuller, J., German, G. J., Haldane, D. J. M., Hoang, L., Jiao, L., Kus, J. V., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01803-25 · Cited by 3 · see citing works
Hypermutator fungal pathogens: from threat to meltdown
Baril, T., & Croll, D. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.07.006 · Cited by 2 · see citing works
Wojak, K. P., Ungermann, G. F., Ichsan, I., Gómez-Molero, E., Jung, K., Weig, M., Nauck, F., Ziebolz, D., Gräser, Y., Nau, R., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9081627 · Cited by 1 · see citing works
Applications of Long-Read Sequencing Technology in Clinical Genomics
Sathyanarayana, S. H., Deharvengt, S. J., Huang, G., Barney, R. E., Shah, P. S., & Lefferts, J. A. (2022) · Advances in Molecular Pathology · doi:10.1016/j.yamp.2022.07.004 · Cited by 1 · see citing works
Uncovering actionable trade-offs of antifungal resistance in a yeast pathogen
Nunez‐Rodriguez, J. C., Schikora-Tamarit, M. À., & Gabaldón, T. (2026) · Molecular Systems Biology · doi:10.1038/s44320-025-00185-3 · Cited by 1 · see citing works
Song, Y., Hokken, M., Zoll, J., Venselaar, H., Verweij, P. E., Melchers, W. J. G., & Rhodes, J. L. (2026) · Emerging Microbes & Infections · doi:10.1080/22221751.2026.2627078 · Cited by 1 · see citing works
Candida glabrata and the host: a neglected affair
Ghosh, M., Raney, M., & Kaur, R. (2026) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002161 · Cited by 1 · see citing works
Using Bioluminescence to Image Candida glabrata Urinary Tract Infections in Mice
Schrevens, S., Torelli, R., Sanguinetti, M., & Sanglard, D. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3155-3_17 · Cited by 1 · see citing works
Self-citationWei, K., Arlotto, M., Overhulse, J. M., Dinh, T., Zhou, Y., Dupper, N. J., Yang, J., Kashemirov, B. A., Dawi, H., Garnaud, C., et al. (2025) · Advanced Science · doi:10.1002/advs.202404260 · Cited by 1 · see citing works
Fróis-Martins, R., Mertens, S., Tran, V. D. T., Maufrais, C., d’Enfert, C., Sanglard, D., & LeibundGut‐Landmann, S. (2026) · mBio · doi:10.1128/mbio.00415-26 · Cited by 2 · see citing works
Self-citationCarolus, H., Biriukov, V. V., Vreys, J., Romero, C. L., Ávila, J. P. H., Vergauwen, R., Sofras, D., Nysten, J. V., Vanreppelen, G., Vinken, L., et al. (2026) · mBio · doi:10.1128/mbio.00588-26
López-Marmolejo, A. L., Hernández-Chávez, M. J., Gutiérrez‐Escobedo, G., Varela‐Castillo, P., Herrera-Basurto, M. S., Martínez‐Gamboa, R. A., González-Lara, M. F., Sifuentes‐Osornio, J., Peñas, A. D. L., & Castaño, I. (2026) · Medical Mycology · doi:10.1093/mmy/myag077
- Authors
- Vale-Silva, L., Beaudoing, E., Tran, V. D. T., & Sanglard, D.
- Affiliations
- Institute of Microbiology, University of Lausanne, CH-1011, Switzerland
- Center for Integrative Genomics, Lausanne Genomic Technologies Facility, CH-1015, Switzerland
- SIB Swiss Institute of Bioinformatics (CH)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Sanglard, Dominique
- Venue
- G3 Genes|Genomes|Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-01
- Volume
- 7
- Issue
- 8
- Pages
- 2413-2426
- ISSN
- 2160-1836 (ISSN-L)
- PMC
- PMC5555451
- OpenAlex
- W2951922435
- Semantic Scholar
- ac0f3cdd53cc46eb63c428de6dbb9d93f051e6b5
- Cited by
- 61
- References
- 58
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 11 · 2021: 8 · 2020: 4 · 2019: 9 · 2018: 10 · 2017: 1
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- G3 Genes Genomes Genetics (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- IRIS (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- Université de Lausanne
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Keywords
- antifungal resistance, azole resistance, multidrug efflux transporter, virulence, retrotransposons, hypermutator phenotype, genome rearrangement, clinical isolates, host adaptation, mitochondrial genome
- MeSH terms
- Fungal Proteins, Humans, Nucleotides, Genetic Variation, Chromosomes, Fungal, Genome, Fungal, Polymorphism, Single Nucleotide, Genomics, Candida glabrata, INDEL Mutation, Molecular Sequence Annotation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review